Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 600 is a DNA-binding transcription factor that contains zinc finger domains and is predicted to be involved in the regulation of transcription by RNA polymerase II[3]. It is primarily localized to the cell nucleus and has predicted functions in nucleic acid binding and transcriptional regulation. There is evidence of variable expression in normal and cancer tissues, with some studies examining its association to cancer prognosis, but there are no known direct therapeutic drugs or established biomarker or safety profiles for this molecule[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 600 (ZNF600).